Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin

Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin

Abstract Background Kaposi’s sarcoma (KS) is a common HIV-associated malignancy frequently associated with poor outcomes. It is the most frequently diagnosed cancer in major cities of Mozambique. Antiretroviral therapy is the cornerstone of KS treatment, but many patients require cytotoxic chemother...

Full description

Bibliographic Details
Main Authors: Matthew E. Coldiron, Ana Gabriela Gutierrez Zamudio, Rolanda Manuel, Gilda Luciano, Barbara Rusch, Iza Ciglenecki, Alex Telnov, Rebecca F. Grais, Laurence Toutous Trellu, Lucas Molfino
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Infectious Agents and Cancer
Subjects:
Kaposi sarcoma
Acquired immunodeficiency syndrome
Mozambique
AIDS-related opportunistic infections
Doxorubicin
Online Access:https://doi.org/10.1186/s13027-020-00341-4

Similar Items

Similar Items